Welcome to our dedicated page for Albertsons Companies SEC filings (Ticker: ACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Albertsons Companies, Inc. filings document material events for a public food and drug retailer, including furnished operating results, Regulation FD disclosures, board changes, and financing transactions. Recent 8-Ks cover quarterly and annual financial results, opioid-related claim disclosures, director appointments and resignations, and senior note offerings or refinancings involving the company and subsidiary co-issuers such as Safeway Inc., New Albertsons L.P., Albertson's LLC and Albertsons Safeway LLC.
The filing record also describes capital-structure terms for senior notes due 2031, 2032 and 2034, use of proceeds for debt refinancing and revolver repayment, stockholder-agreement governance matters, Class A common stock ownership references, exhibits, and Inline XBRL cover-page data.
Albertsons Companies (ACI) reported an insider transaction by EVP & Chief HR Officer Michael Theilmann. On October 16, 2025, he sold 100,000 shares of Class A common stock at a weighted‑average price of $19.351.
The filing notes multiple trades executed between $19.34 and $19.40. After these sales, he beneficially owned 338,429 shares directly.
Albertsons Companies (ACI) officer Anuj Dhanda reported an open-market sale of 230,000 shares of Class A common stock at a $19.249 weighted average price on October 16, 2025.
The filing notes executions across a price range of $19.195–$19.295, with details available upon request. After the transaction, Dhanda beneficially owned 300,577 shares, held directly.
Albertsons Companies (ACI) disclosed a Form 144 notice for a proposed sale of up to 17,815 Class A shares with an aggregate market value of $351,849.81. The filing lists Fidelity Brokerage Services LLC as broker and an approximate sale date of 10/17/2025 on the NYSE.
The shares were acquired via restricted stock vesting on 02/22/2025 as compensation. Shares outstanding were 549,307,530.
ACI received a Form 144 notice for a proposed sale of 230,000 shares of common stock with an aggregate market value of $4,427,441.08. The filing lists Fidelity Brokerage Services LLC as broker and the NYSE as the exchange, with an approximate sale date of 10/16/2025.
The shares were acquired through restricted stock vesting on multiple dates—02/26/2022 (37,822), 02/25/2023 (71,806), 02/27/2023 (20,538), 08/05/2024 (99,581), and 08/09/2024 (253)—totaling 230,000. Shares outstanding were 549,307,530.
A selling stockholder filed a Form 144 notice to sell up to 100,000 shares of Class A common stock. The filing lists an aggregate market value of $1,935,144.77, with an approximate sale date of October 16, 2025. The proposed sales would be executed through Fidelity Brokerage Services LLC on the NYSE.
The shares were acquired via restricted stock vesting from the issuer as compensation, in lots of 2,500 (06/26/2020), 14,395 (02/27/2021), 23,546 (05/05/2021), 19,070 (08/19/2021), and 40,489 (02/26/2022), totaling 100,000 shares. The filing table also lists 549,307,530 shares outstanding; this is a baseline figure, not the amount being offered.
Albertsons Companies (ACI) entered an accelerated share repurchase (ASR) with JPMorgan to repurchase $750 million of common stock as part of its buyback program. The company will pay $750 million on October 15, 2025, and expects an initial delivery of approximately 80% of the shares initially underlying the ASR.
The final number of shares will be determined by the volume‑weighted average price of ACI stock during the ASR term, less a discount, with customary adjustments. The transactions are expected to be completed no later than the first quarter of 2026. The Board also increased the total share repurchase authorization to $2.75 billion, inclusive of this ASR.
Albertsons Companies (ACI) reported steady second‑quarter results. Net sales and other revenue were $18.9 billion, up 2.0% year over year, with net income $168.5 million and EPS $0.30. Identical sales excluding fuel rose 2.2%, driven primarily by strong pharmacy growth. Digital sales increased 23%, and loyalty members grew 13% to 48.7 million.
Gross margin rate was 27.0% versus 27.6% a year ago, reflecting mix shift toward pharmacy and higher delivery and handling costs from digital, partially offset by productivity initiatives. For the first 28 weeks of fiscal 2025, cash from operations totaled $1,282.0 million; capital expenditures were $950.5 million.
Capital returns included $169.6 million in dividends and repurchase of 25.7 million shares for $550.1 million. Subsequent to quarter end, ACI entered a $750 million accelerated share repurchase and increased its authorization to $2.75 billion. The company issued $600 million 6.250% notes due 2033 to redeem 2026 notes and amended its $4.0 billion ABL facility to extend maturity to 2030, with $325.0 million outstanding. A pension annuity purchase transferred $290.0 million of assets, resulting in a $26.8 million settlement gain.
Albertsons Companies, Inc. (ACI) furnished a press release announcing its financial results for the 12 and 28 weeks ended September 6, 2025. The press release is provided as Exhibit 99.1. The company noted that this information is furnished and not deemed filed under the Exchange Act, and is not incorporated by reference except as expressly set forth by specific reference.
Albertsons Companies, Inc. (ACI) director David Zinsner was granted 4,603 time-based restricted stock units (RSUs) on 09/23/2025. Each RSU represents a contractual right to receive one share of Class A common stock.
The award will vest in full on February 28, 2026 provided Zinsner continues to serve as a director through that date. The Form 4 was signed on behalf of Mr. Zinsner by Maria Fernandez on 09/24/2025.
David Zinsner, reporting as a director of Albertsons Companies, Inc. (ACI), filed an initial Section 16 Form 3 reporting the event date 09/15/2025. The filing states the reporting person does not beneficially own any securities of the issuer as of the report date. The Form 3 was signed by an attorney-in-fact on behalf of Mr. Zinsner on 09/22/2025, indicating a timely initial disclosure with no holdings reported.